These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 16406327

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The protein profile of acetazolamide-treated sera in mice bearing Lewis neoplasm.
    Xiang Y, Ma B, Yu HM, Li XJ.
    Life Sci; 2004 Jul 30; 75(11):1277-85. PubMed ID: 15234186
    [Abstract] [Full Text] [Related]

  • 3. [Inhibitory effect of huangqi and dangshen extraction with pacilitaxel on metastasis and angiogenesis on mouse Lewis lung carcinoma model].
    Bai CQ, Song YF, Wang DT, Guo HL.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Apr 30; 24(4):375-7. PubMed ID: 18394349
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But.
    Coradini D, Zorzet S, Rossin R, Scarlata I, Pellizzaro C, Turrin C, Bello M, Cantoni S, Speranza A, Sava G, Mazzi U, Perbellini A.
    Clin Cancer Res; 2004 Jul 15; 10(14):4822-30. PubMed ID: 15269158
    [Abstract] [Full Text] [Related]

  • 5. [Combined low-dose chemotherapy inhibiting angiogenesis and growth of Lewis lung cancinoma xenografts in mice].
    Qiu M, Yi C, Hou M.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul 15; 37(4):534-7. PubMed ID: 16909595
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model.
    Hu L, Hofmann J, Holash J, Yancopoulos GD, Sood AK, Jaffe RB.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6966-71. PubMed ID: 16203789
    [Abstract] [Full Text] [Related]

  • 7. Prevention of local tumor growth with paclitaxel-loaded microspheres.
    Azouz SM, Walpole J, Amirifeli S, Taylor KN, Grinstaff MW, Colson YL.
    J Thorac Cardiovasc Surg; 2008 May 01; 135(5):1014-21. PubMed ID: 18455578
    [Abstract] [Full Text] [Related]

  • 8. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J, Nevozhay D, Filip B, Milczarek M, Kutner A.
    Anticancer Res; 2007 May 01; 27(5A):3387-98. PubMed ID: 17970085
    [Abstract] [Full Text] [Related]

  • 9. Angiostatin potentiates cyclophosphamide treatment of metastatic disease.
    Mauceri HJ, Seetharam S, Beckett MA, Schumm LP, Koons A, Gupta VK, Park JO, Manan A, Lee JY, Montag AG, Kufe DW, Weichselbaum RR.
    Cancer Chemother Pharmacol; 2002 Nov 01; 50(5):412-8. PubMed ID: 12439600
    [Abstract] [Full Text] [Related]

  • 10. Anti-tumor and anti-angiogenic effects of Phyllanthus urinaria in mice bearing Lewis lung carcinoma.
    Huang ST, Yang RC, Lee PN, Yang SH, Liao SK, Chen TY, Pang JH.
    Int Immunopharmacol; 2006 Jun 01; 6(6):870-9. PubMed ID: 16644472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.
    Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K.
    Exp Biol Med (Maywood); 2009 Oct 01; 234(10):1244-52. PubMed ID: 19657067
    [Abstract] [Full Text] [Related]

  • 13. Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma.
    Xiang Y, Ma B, Li T, Yu HM, Li XJ.
    Acta Pharmacol Sin; 2002 Aug 01; 23(8):745-51. PubMed ID: 12147198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
    Rosato A, Banzato A, De Luca G, Renier D, Bettella F, Pagano C, Esposito G, Zanovello P, Bassi P.
    Urol Oncol; 2006 Aug 01; 24(3):207-15. PubMed ID: 16678050
    [Abstract] [Full Text] [Related]

  • 16. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
    Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ.
    Oncol Rep; 2008 Sep 01; 20(3):581-7. PubMed ID: 18695909
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor immunoneutralization in combination with cisplatin reduces EAC tumor growth.
    Ghosh S, Maity P.
    Int Immunopharmacol; 2006 Oct 01; 6(10):1550-9. PubMed ID: 16919827
    [Abstract] [Full Text] [Related]

  • 19. In vitro and in vivo histone deacetylase inhibitor therapy with suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer.
    Cooper AL, Greenberg VL, Lancaster PS, van Nagell JR, Zimmer SG, Modesitt SC.
    Gynecol Oncol; 2007 Mar 01; 104(3):596-601. PubMed ID: 17049973
    [Abstract] [Full Text] [Related]

  • 20. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
    Yuan Z, Yan F, Wang YS, Liu HY, Gou LT, Zhao XY, Lai ST, Deng HX, Li J, Ding ZY, Xiong SQ, Kan B, Mao YQ, Chen LJ, Wei YQ, Zhao X.
    Cancer Chemother Pharmacol; 2009 Dec 01; 65(1):13-25. PubMed ID: 19387645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.